@csk33kimo

Infectious Diseases physician in Taipei, Taiwan. 🌏 Dad to two girls. 💕 Drive Peugeot 408 and 508sw. 🚗

 Taiwan
Joined August 2011
  • Tweets404
  • Following524
  • Followers92
74Media
Sheng-Kang Chiu 邱勝康 retweeted
Kohei Hasegawa@kbot13533737Oct 17
S. aureusのメチシリン耐性機序と新しい分類・命名法 - CMI (2026) 3つにカテゴリー ①mec依存性MRSA ②mec非依存性耐性株 (MRLM) ③オキサシリン感受性mecA陽性株 (OS-MRSA) MPIPCではなくCFXを標準的な表現型検査として推奨 遺伝子検査ができる前提ですね 面白いです clinicalmicrobiologyandinfec…
21
90
3,483
🆕🔥🟢 Review @jac_amr When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections? #idxposts academic.oup.com/jacamr/arti…
1
43
105
8,301
Sheng-Kang Chiu 邱勝康 retweeted
Medicos🧑‍⚕️@NursingmedicosAug 1
2
55
192
4,116
Sheng-Kang Chiu 邱勝康 retweeted
1-min ID consult@1min_IDconsultJul 16
【Durations of Therapy for Diabetic Foot Infections】 Let's remember the typical durations of therapy for DFI! (of course case by case) Level: Intermediate @CIDJournal @Cortes_Penfield @JonathanRyderMD @DGArmstrong @TzeWoeiTan @limbsandlungs @IDSAMedEdCOP
1
31
129
9,199
Sheng-Kang Chiu 邱勝康 retweeted
د. محمد المنصور
@123mMohammedJul 9
💊 الخيارات العلاجية للحزام الناري Initial management of adults with uncomplicated herpes zoster هل حضر المريض خلال آخر 72 ساعة من ظهور الطفح الجلدي ؟ 🔸نعم : نبدأ العلاج باستخدام أحد الأدوية التالية : 💊فالاسايكلوفير : 1000 ملغ ثلاث مرات يوميًا 💊فامسايكلوفير : 500 ملغ ثلاث مرات يوميًا 💊أسايكلوفير : 800 ملغ خمس مرات يوميًا 🔺 فالاسايكلوفير أو فامسايكلوفير افضل في غير الحوامل لأنها تتطلب جرعات أقل من اسايكلوفير 🔺 أسايكلوفير هو الأفضل للحامل لوجود خبرة أوسع باستخدامه 🔺العلاج يستمر حتى يتقشر جميع الطفح الجلدي ، وعادةً يحتاج 7 أيام في المرضى بدون نقص مناعة ، و 7–14 يوم لمرضى نقص المناعة 🔸لا : حضر المريض بعد 72 ساعة 5️⃣هل توجد ظروف قد تجعل العلاج لا يزال مفيد بعد مرور 72 ساعة ؟ 🔹مثل : 🔸عمر المريض أكبر من 65 سنة ملاحظة : لا يوجد عمر محدد ، لكن المناعة ضد الفيروس تضعف مع التقدم في العمر 🔸وجود طفح جلدي في مناطق حساسة مثل عصب العين ( V1 dermatome ) 🔸ظهور طفح جلدي جديد بعد مرور 72 ساعة _ نعم : ابدأ العلاج الفموي كما هو موضح أعلاه _ لا : لا يُوصى بالعلاج ♦️التقييم و العلاج بعد استشارة الطبيب ♦️UpToDate
2
47
186
10,302
Sheng-Kang Chiu 邱勝康 retweeted
K.Ishikawa, MD, Ph.D, MPH, MSc
@hiro_0921jpJul 10
PEN-FASTの前にできることもある。
1
4
344
Sheng-Kang Chiu 邱勝康 retweeted
Wataru Hayashi / 林 航@DraWataruJun 30
病原体検出マニュアル カルバペネム耐性腸内細菌目細菌（CRE） 令和 8 年 4 月改訂版_Ver3.1 id-info.jihs.go.jp/manuals/p…
2
17
2
72
12,939
Sheng-Kang Chiu 邱勝康 retweeted
Jose Ramos Vivas
@joseramosvivasJun 13
🚨 🇪🇺🦠La resistencia a antibióticos en hospitales europeos sigue siendo una amenaza grave. The Lancet Microbe nos dice que Klebsiella pneumoniae muestra una persistencia y expansión de linajes de alto riesgo productores de carbapenemasas en hospitales de 36 países europeos. 🧬🏥 Lo más preocupante: 📉 Las medidas de control no han logrado interrumpir la transmisión de estos linajes. 📈 Linajes como ST307 aumentaron entre los aislados carbapenem-R/I analizados. 🦠 El 89,3% de los aislados carbapenem-R/I portaban genes de carbapenemasa, y también se observó mayor presencia de genes de virulencia adquiridos. 🧬La vigilancia genómica ayuda a mapear esta amenaza y a adaptar diagnóstico, tratamiento y control. 🛡️ 👉👇🏻 doi.org/10.1016/j.lanmic.202… #AMR #ResistenciaAntibioticos #SaludPública #Microbiología #VigilanciaGenomica #OneHealth #Klebsiella @SEMicrobiologia @SEIMC_ @ANIH_1
37
56
2,026
Sheng-Kang Chiu 邱勝康 retweeted
Brad Spellberg@BradSpellbergJun 13
Thanks to @highlycritical1 for finding new Shorter Is Better RCT for CAP! This is the 15th RCT showing 3-5 d = 7-14 days. And thanks to @Zaydovudine for finding 1996 RCT of amox 6 d vs. PCN V 14 d for GAS pharyngitis! Both added to the tables and website. bradspellberg.com/shorter-is…
4
25
62
9,134
🆕💥🔴Multicenter retrospective study of ICU patients with pneumonia BIOFIRE® PN Panel implementation was associated with improved early antimicrobial de-escalation and appropriate therapy, with the greatest benefit in hospitals with comprehensive antimicrobial stewardship infrastructure #idxposts academic.oup.com/cid/article…

Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare...

In this national, multicenter retrospective study of intensive care unit patients with pneumonia in Veterans Health Administration hospitals, BIOFIRE® PN P

academic.oup.com
1
34
2
66
6,488
🆕🔥SCOUT RCT* The RCT found that Nitrofurantoin was the most effective treatment and single-dose fosfomycin the least effective treatment for UTIs #ESCMIDGlobal2026 thelancet.com/journals/lance…
3
45
1
152
17,582
Sheng-Kang Chiu 邱勝康 retweeted
Takahiro Matsuo (Taka), MD@TakaMatsuo_IDApr 23
【Spinal Epidural Abscess】@NEJM Apr 22, 2026 My mentor @MDTande @MayoClinicINFD and team has published epidural abscess in NEJM! Very useful Figures/Tables! 👉Please check it out! nejm.org/doi/full/10.1056/NE… #IDMedEd #IDFellow #OrthoID #Keyarticle
39
123
6,388
Sheng-Kang Chiu 邱勝康 retweeted
Joseph Sassine@JosephSassineMD10 Nov 2024
Our large database analysis @TriNetX of viral and fungal infections after CAR T cell therapy is out now at @CMIJournal! With @Emily_Siegrist @andhen25 @RitaWilsonDib1 @joseandres2910 @DBChastain @chiayuchiuID et al. @OUCollegeofMed #TxID #lymsm #mmsm 🧵 clinicalmicrobiologyandinfec…
2
19
1
39
3,477
🔥Just published🔥 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 : Critical Care Medicine #IDXposts share.google/VN4AfbchzDiRr7e…
5
119
5
369
137,815
Sheng-Kang Chiu 邱勝康 retweeted
Timothy Li@drtimothyliFeb 16
"Cefazolin does not share any side chains with the currently available penicillins and can be used in cases of suspected or proven immediate type allergy to a penicillin, irrespective of severity or time elapsed since the index reaction." ⭐Surgical prophylaxis ⭐MSSA infection
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟
@ABstewardFeb 16
🔥Just published 🔥 ESCMID Clinical Guidelines on the Evaluation and Management of a Reported Antibiotic Allergy #IDXposts clinicalmicrobiologyandinfec…
Beta lactams flow shart

ALT Beta lactams flow shart

1
78
1
250
26,236
Sheng-Kang Chiu 邱勝康 retweeted
IDSA
@IDSAInfoJan 28
Subcutaneous antibiotic administration is increasingly recognized as a valuable alternative to intravenous therapy in select contexts. In @CIDJournal, authors summarize current clinical experience, PK/PD data, & technical aspects of subcutaneous infusion. academic.oup.com/cid/advance…

When and How to Use Subcutaneous Antibiotics

Subcutaneous administration of selected antibiotics provides a practical, safe alternative to intravenous therapy in patients with poor venous access, in o

academic.oup.com
48
2
112
8,383
Sheng-Kang Chiu 邱勝康 retweeted
Wataru Hayashi / 林 航@DraWataruJan 28
Antimicrobial Resistance in ESKAPE Pathogens | Clinical Microbiology Reviews (journals.asm.org/doi/10.1128…)
1
56
131
5,625
Sheng-Kang Chiu 邱勝康 retweeted
Netflix Sports
@netflixsportsJan 25
Alex Honnold taking a selfie at the top of Taipei 101 after free soloing the skyscraper. UNBELIEVABLE!!! #SkyscraperLIVE
337
2,277
503
13,270
1,119,793
Sheng-Kang Chiu 邱勝康 retweeted
Nature Metabolism
@NatMetabolism26 Dec 2025
#Throwback PERSPECTIVE | R Chakaroun, P Kovacs et al. Tissue-resident bacteria in metabolic diseases: emerging evidence and challenges nature.com/articles/s42255-0…

Tissue-resident bacteria in metabolic diseases: emerging evidence and challenges

Nature Metabolism - In this Perspective, the role of tissue-resident bacteria in metabolic diseases is discussed and the experimental challenges that this emerging field is facing are highlighted.

nature.com
7
100
4,659
Sheng-Kang Chiu 邱勝康 retweeted
NEJM
@NEJM14 Dec 2025
Antibiotic duration for bacteremia is something most of us learned by habit, not by trial data. In the latest episode of Beyond Journal Club, a collaboration between @COREIMpodcast and NEJM Group, we walk through the BALANCE trial and use it as a lens to revisit how the factors of host, organism, and source should guide treatment; when is shorter really enough, and when isn’t it? 🎧 Listen to the full episode: nej.md/3XNgajK 📖 Further reading  Original Article by N. Daneman et al.: Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections nej.md/3Z5bTJD
An illustration explaining the BALANCE trial

ALT An illustration explaining the BALANCE trial

3
219
3
601
51,980
Load more